Press Release

Awarded “A Rank Certification” by the Kyoto City Venture Business Connoisseur Committee.

2019.10.23

On September 27, 2019, the Kyoto City Venture Business Connoisseur Committee held its final review and approved our business plan for “Development of regenerative medicine products using novel human neural stem cells “OligoGenie”” as rank A.

Exhibited and spoke at "Innovation Japan 2019" (Aug. 29-30).
Participated and spoke at "Bio Japan 2019" (Oct. 9-11/2019).

Latest posts

2023.11.29 IR
Participate and speak at the “Innovation Leaders Summit 2023” (Dec. 5).
2023.10.31 Press Release
The 8th Annual General Meeting of Shareholders was held.
2023.07.13 News
Participate and speak at the “KLSAP2023 Pitch Event” (Jul. 14).
2023.06.22 News
Notice of website maintenance
2023.06.01 IR
Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).
2022.11.01 Press Release
We will start joint research with Mochida Pharmaceutical Co. ,Ltd
2022.10.30 Press Release
We reported the financial results at the regular general meeting of shareholders.
2021.11.01 IR
Notice Concerning Issuance of Stock Acquisition Rights through Crowdfunding
2021.09.01 R&D
Research and development of exosomes will be resumed.
2021.03.16 News
“ACHIEVEMENTS” Page has been updated.

Latest posts

Participate and speak at the “Innovation Leaders Summit 2023” (Dec. 5).

The 8th Annual General Meeting of Shareholders was held.

Participate and speak at the “KLSAP2023 Pitch Event” (Jul. 14).

Notice of website maintenance

Head office moved to Kyoto City Growth Industry Creation Center (ACT Kyoto).

We will start joint research with Mochida Pharmaceutical Co. ,Ltd

We reported the financial results at the regular general meeting of shareholders.

Notice Concerning Issuance of Stock Acquisition Rights through Crowdfunding

Research and development of exosomes will be resumed.

“ACHIEVEMENTS” Page has been updated.